IL109685A - History of quinoline Process for their preparation and pharmaceutical preparations for the prevention of secretion of gastric juices containing them - Google Patents

History of quinoline Process for their preparation and pharmaceutical preparations for the prevention of secretion of gastric juices containing them

Info

Publication number
IL109685A
IL109685A IL10968594A IL10968594A IL109685A IL 109685 A IL109685 A IL 109685A IL 10968594 A IL10968594 A IL 10968594A IL 10968594 A IL10968594 A IL 10968594A IL 109685 A IL109685 A IL 109685A
Authority
IL
Israel
Prior art keywords
compound
quinoline
mmol
methylene chloride
butyryl
Prior art date
Application number
IL10968594A
Other languages
English (en)
Hebrew (he)
Other versions
IL109685A0 (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9302005A external-priority patent/SE9302005D0/xx
Priority claimed from SE9303970A external-priority patent/SE9303970D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL109685A0 publication Critical patent/IL109685A0/xx
Publication of IL109685A publication Critical patent/IL109685A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL10968594A 1993-06-11 1994-05-19 History of quinoline Process for their preparation and pharmaceutical preparations for the prevention of secretion of gastric juices containing them IL109685A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9302005A SE9302005D0 (sv) 1993-06-11 1993-06-11 New active compounds
SE9303970A SE9303970D0 (sv) 1993-11-30 1993-11-30 New active compounds

Publications (2)

Publication Number Publication Date
IL109685A0 IL109685A0 (en) 1994-11-28
IL109685A true IL109685A (en) 1999-03-12

Family

ID=26661770

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10968594A IL109685A (en) 1993-06-11 1994-05-19 History of quinoline Process for their preparation and pharmaceutical preparations for the prevention of secretion of gastric juices containing them

Country Status (25)

Country Link
US (1) US5889021A (de)
EP (1) EP0702672B1 (de)
JP (1) JP3623794B2 (de)
CN (1) CN1045955C (de)
AT (1) ATE196134T1 (de)
AU (1) AU680516B2 (de)
BR (1) BR9406772A (de)
CA (1) CA2164875A1 (de)
CZ (1) CZ326095A3 (de)
DE (1) DE69425823T2 (de)
EE (1) EE03123B1 (de)
EG (1) EG20435A (de)
ES (1) ES2150494T3 (de)
FI (1) FI955896A0 (de)
HU (1) HUT75122A (de)
IL (1) IL109685A (de)
IS (1) IS4164A (de)
NO (1) NO305799B1 (de)
NZ (1) NZ267740A (de)
PL (1) PL177766B1 (de)
RU (1) RU2142454C1 (de)
SG (1) SG47820A1 (de)
SK (1) SK154995A3 (de)
TW (1) TW261613B (de)
WO (1) WO1994029274A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
AU2002950217A0 (en) 2002-07-16 2002-09-12 Prana Biotechnology Limited 8- Hydroxy Quinoline Derivatives
CN109369656B (zh) * 2015-12-31 2021-05-07 上海医药集团股份有限公司 喹啉类化合物硫酸盐的晶型、制备方法、组合物与应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US509804A (en) * 1893-11-28 Hoof-weight
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
US4042702A (en) * 1973-08-16 1977-08-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogen pyrazole derivatives, a method for producing these halogen pyrazole derivatives, medicaments containing and methods of using them
LU69428A1 (de) * 1974-02-20 1975-12-09
US4120966A (en) * 1975-02-03 1978-10-17 Smith Kline & French Laboratories Limited Heterocyclic-methylthioethyl-dithiocarbamates and isothioureas
NO760996L (de) * 1975-03-25 1976-09-28 Byk Gulden Lomberg Chem Fab
US4239901A (en) * 1976-10-14 1980-12-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrazol-1-ylphenylacetic acids
LU78804A1 (de) * 1977-12-30 1979-07-20 Byk Gulden Lomberg Chem Fab N-substituierte w-aminoalkanoyl-w-aminoalkansaeuren,ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US4243678A (en) * 1977-12-30 1981-01-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylhydrocarbylaminoalkanoic acids, compositions and uses
YU118379A (en) * 1978-05-24 1983-02-28 Byk Gulden Lomberg Chemischefa Process for preparing phenylaminothiophene acetic acid
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
CA1154762A (en) * 1979-08-03 1983-10-04 Georg Rainer Substituted tetraazatricyclic compounds, a process for their preparation, their use and medicaments containing them
EP0024638A1 (de) * 1979-08-30 1981-03-11 Byk Gulden Lomberg Chemische Fabrik GmbH Substituierte Chinolinonalkancarbonsäuren, ihre Herstellung und sie enthaltende Arzneimittel
DE3032669A1 (de) * 1979-09-07 1981-04-02 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte oxirancarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
ES8202780A1 (es) * 1979-10-31 1982-03-01 Byk Gulden Lomberg Chem Fab Procedimiento para la preparacion de acidos oxocarboxilicos sustituidos
US4381301A (en) * 1980-05-07 1983-04-26 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted tricyclic thieno compounds, their synthesis, their use, their compositions and their medicaments
US4337267A (en) * 1980-08-25 1982-06-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenalkoxyalkyl- and phenoxyalkyl-substituted oxiranecarboxylic acids, their use and medicaments containing them
JPS57501478A (de) * 1980-08-29 1982-08-19
EP0057428B1 (de) * 1981-02-02 1985-04-10 Byk Gulden Lomberg Chemische Fabrik GmbH Tricyclische Pyrrole, Verfahren zu ihrer Herstellung, ihre Anwendung sowie sie enthaltende Arzneimittel
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
EP0187977B1 (de) * 1984-12-18 1990-08-29 Otsuka Pharmaceutical Co., Ltd. Tetrahydrochinolin- Derivate, Verfahren zu deren Herstellung und diese enthaltende Antimagengeschwürzusammensetzungen
US5250527A (en) * 1985-10-24 1993-10-05 Smithkline & French Laboratories Limited Pyridyl containing benzimidazoles, compositions and use
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8717644D0 (en) * 1987-07-24 1987-09-03 Smithkline Beckman Intercredit Compounds
US5049567A (en) * 1988-02-25 1991-09-17 Smithkline Beckman Intercredit B.V. Substituted 4-aminoquinazoline derivatives and method of use
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
GB8908229D0 (en) * 1989-04-12 1989-05-24 Smithkline Beckman Intercredit Compounds
GB8910722D0 (en) * 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
AU634880B2 (en) * 1990-03-28 1993-03-04 Otsuka Pharmaceutical Co., Ltd. Quinoline derivative, antiulcer drug containing the same, and production of said derivative
CZ153293A3 (en) * 1991-01-29 1993-12-15 Smithkline Beecham Intercredit Salts of 4-amino-acylquinoline derivative
GB9126438D0 (en) * 1991-12-12 1992-02-12 Smithkline Beecham Intercredit New quinoline derivatives

Also Published As

Publication number Publication date
ATE196134T1 (de) 2000-09-15
RU2142454C1 (ru) 1999-12-10
NO954928D0 (no) 1995-12-05
CA2164875A1 (en) 1994-12-22
FI955896A (fi) 1995-12-08
TW261613B (de) 1995-11-01
CN1125438A (zh) 1996-06-26
EP0702672B1 (de) 2000-09-06
DE69425823T2 (de) 2001-01-18
JP3623794B2 (ja) 2005-02-23
AU7012194A (en) 1995-01-03
BR9406772A (pt) 1996-02-21
AU680516B2 (en) 1997-07-31
HU9503529D0 (en) 1996-02-28
NO305799B1 (no) 1999-07-26
EE03123B1 (et) 1998-10-15
WO1994029274A1 (en) 1994-12-22
PL311957A1 (en) 1996-03-18
IS4164A (is) 1994-12-12
SK154995A3 (en) 1996-09-04
EP0702672A1 (de) 1996-03-27
NO954928L (no) 1995-12-05
CZ326095A3 (en) 1996-05-15
FI955896A0 (fi) 1995-12-08
ES2150494T3 (es) 2000-12-01
PL177766B1 (pl) 2000-01-31
SG47820A1 (en) 1998-04-17
NZ267740A (en) 1997-05-26
US5889021A (en) 1999-03-30
HUT75122A (en) 1997-04-28
IL109685A0 (en) 1994-11-28
DE69425823D1 (de) 2000-10-12
CN1045955C (zh) 1999-10-27
EG20435A (en) 1999-04-29
JPH09510951A (ja) 1997-11-04

Similar Documents

Publication Publication Date Title
JP3883383B2 (ja) 胃酸分泌を阻害するイミダゾピリジン誘導体
AP215A (en) Substituted benzimidazoles, process for their preparation and their pharmaceutical use.
NO317304B1 (no) Tetrahydropyridoetere
WO1995027714A1 (en) Active compounds
US5889021A (en) Active Compounds
JPS63502658A (ja) 新規な物質の組成
US5556863A (en) Compound for gastric acid secretion inhibition
SK197A3 (en) Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use
EP0302371B1 (de) 7-(2-Methyl-4-aminopyrrolidinyl)naphthyridin und Chenolin-Verbindungen
AU617181B2 (en) Quinolonecarboxylic acids
EP0197318B1 (de) Benzo[c]-1,5-naphthyridine, ein Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CZ20021981A3 (cs) Heterocyklické deriváty
LT3537B (en) Quinoline derivatives
WO1991016311A1 (en) 7-(substituted hydrazino)-4-oxoquinoline-3-carboxylic acid derivative, its salt and its ester
JPH01258680A (ja) ４，８‐ジヒドロ‐８‐アリールイソキサゾロ〔４，３‐ｅ〕〔１，４〕‐オキサゼピン‐５（６Ｈ）‐オン

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees